ResMed RMD Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.4B+37.2% | $1.02B+13.7% | $897.56M+15.2% | $779.44M+64.3% | ||
| $198.47M+12.2% | $176.87M+7.1% | $165.16M+3.5% | $159.61M+1.8% | ||
| $91.66M+14.3% | $80.18M+12.7% | $71.14M+9.0% | $65.26M+2.1% | ||
| $1.75B+25.0% | $1.4B+102% | $693.3M+97.4% | $351.15M-52.3% | ||
| $89.87M-9.6% | $99.46M-16.9% | $119.67M-11.2% | $134.84M+31.3% | ||
| $139.25M+4.3% | $133.46M-86.8% | $1.01B+2,267% | $42.78M— | ||
| -$200.05M+25.8% | -$269.78M+76.7% | -$1.16B-404% | -$229.92M-45.1% | ||
| $310.88M+10.1% | $282.32M+9.3% | $258.28M+5.3% | $245.34M+8.2% | ||
| $300.03M+100% | $150.01M— | —— | $0— | ||
| $40M-95.2% | $835M+106% | $405M+144% | $166M-72.9% | ||
| -$606.25M+45.8% | -$1.12B— | —— | —— | ||
| $971.09M+9,175% | $10.47M— | —— | —— | ||
| $1.66B+27.6% | $1.3B+127% | $573.63M+165% | $216.31M-65.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ResMed generate?
- ResMed (RMD) generated $1.9B in operating cash flow over the trailing twelve months.
- What is ResMed's free cash flow?
- After $135.7M of capital expenditures, ResMed's free cash flow was $1.8B over the trailing twelve months, up 11.8% year over year.
- Where does ResMed's cash flow data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
